TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6992570

Group type: EXPERIMENTAL
Intervention: Carbenicillin plus trimethoprim-sulfamethoxazole (C-T/S)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Carbenicillin plus gentamicin (C-G)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Combined results of C-T/S
Number of subjects: 126

Group type: COMPARATOR
Intervention: Combined results of C-G
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: C-T/S
Number of subjects: 126

Group type: COMPARATOR
Intervention: C-G
Number of subjects: 126
Study: 31318923

Group type: EXPERIMENTAL
Intervention: Regression group (n = 113)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Validation group (n = 24)
Number of subjects: 137
Study: 28538515

Group type: EXPERIMENTAL
Intervention: Blue wave stimulus with short-wavelength light (460 nm)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Green wave stimulus with middle-wavelength light (555 nm)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Short-wavelength light exposure
Number of subjects: 28
Study: 26551645

Group type: EXPERIMENTAL
Intervention: Dehydrated human amnion/chorion membrane (dHACM) allograft
Number of subjects: 44

Group type: COMPARATOR
Intervention: Multilayer compression only
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall correlation of status at 4 weeks
Number of subjects: 44
Study: 23721792

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis plus circumcision
Number of subjects: 197

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis only
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group (uncircumcised boys without VUR)
Number of subjects: 197
Study: 20800361

Group type: EXPERIMENTAL
Intervention: Stress exposure
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 76
Study: 18479485

Group type: EXPERIMENTAL
Intervention: Semiparametric maximum likelihood estimate (SPMLE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximum estimated likelihood estimator (MELE)
Number of subjects: 0
Study: 17825687

Group type: EXPERIMENTAL
Intervention: P‐OM3 plus simvastatin 40 mg/d
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo plus simvastatin 40 mg/d
Number of subjects: 254
Study: 15475724

Group type: EXPERIMENTAL
Intervention: 24-hour diet recalls
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Food frequency questionnaires (FFQs)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Joint predictors of 24-hour diet recalls and FFQs
Number of subjects: 395
Study: 16210253

Group type: EXPERIMENTAL
Intervention: Risk score based on 16 clinical variables
Number of subjects: 7311

Group type: EXPERIMENTAL
Intervention: Risk score model for all-cause death, myocardial infarction, and stroke
Number of subjects: 7311
Study: 10482999

Group type: EXPERIMENTAL
Intervention: Negative immunomagnetic ex vivo purging
Number of subjects: 13
Study: 8739853

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (non-responders to interferon)
Number of subjects: 110
Study: 1654364

Group type: EXPERIMENTAL
Intervention: 600 mg of acyclovir five times daily for 10 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 600 mg of acyclovir
Number of subjects: 120
Study: 6886352

Group type: EXPERIMENTAL
Intervention: Atropine plus meperidine (Group 2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Meperidine alone (Group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Endoscopy (after premedication)
Number of subjects: 45
Study: 31965238

Group type: EXPERIMENTAL
Intervention: Periodontitis
Number of subjects: 27
Study: 30224275

Group type: EXPERIMENTAL
Intervention: Emotion-oriented silence
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Emotion-oriented speech
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard communication
Number of subjects: 217
Study: 23494593

Group type: EXPERIMENTAL
Intervention: Postoperative drainage for 5 days or drain removal when less than 50 mL/24 h
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional drain removal
Number of subjects: 214
Study: 24710800

Group type: EXPERIMENTAL
Intervention: Vaginal Hysterectomy (VH)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 108
Study: 22264134

Group type: EXPERIMENTAL
Intervention: FM-MP (Face Mask with Miniplates)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: FM-RME (Face Mask with Rapid Maxillary Expansion)
Number of subjects: 20
Study: 19182619

Group type: EXPERIMENTAL
Intervention: Circumferential negative-pressure wound therapy at -400 mmHg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Circumferential negative-pressure wound therapy at -125 mmHg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Noncircumferential negative-pressure wound therapy at -400 mmHg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Noncircumferential negative-pressure wound therapy at -125 mmHg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Circumferential negative-pressure wound therapy at -400 mmHg vs -125 mmHg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Noncircumferential negative-pressure wound therapy at -400 mmHg vs -125 mmHg
Number of subjects: 32
Study: 17402668

Group type: COMPARATOR
Intervention: Monocular switch procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prismatic displacement
Number of subjects: 0
Study: 15339325

Group type: EXPERIMENTAL
Intervention: Sphincter repair plus biofeedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sphincter repair
Number of subjects: 38
Study: 11524060

Group type: EXPERIMENTAL
Intervention: Implanted cardioverter-defibrillator therapy
Number of subjects: 0
Study: 9519950

Group type: EXPERIMENTAL
Intervention: Isoniazid (twice weekly for 24 weeks)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Rifampicin and pyrazinamide (twice weekly for 8 weeks)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Rifampicin and pyrazinamide
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Isoniazid
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Baseline CD4 percentages <20
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Total mortality
Number of subjects: 750
Study: 8026409

Group type: EXPERIMENTAL
Intervention: High Vagus Nerve Stimulation (VNS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Low Vagus Nerve Stimulation (VNS)
Number of subjects: 67
Study: 29247985

Group type: EXPERIMENTAL
Intervention: Slow movement resistance training using body weight (SRT-BW) for 12 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study: 28285771

Group type: EXPERIMENTAL
Intervention: Olanzapine plus sertraline
Number of subjects: 142

Group type: COMPARATOR
Intervention: Olanzapine plus placebo
Number of subjects: 142
Study: 25499543

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (50,000 IU)
Number of subjects: 31999

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31999
Study: 24163529

Group type: EXPERIMENTAL
Intervention: Tranexamic acid microinjections
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tranexamic acid with microneedling
Number of subjects: 60
Study: 21367351

Group type: EXPERIMENTAL
Intervention: Quality pharmacotherapy
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Adequate dose of antianxiety medication
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Counseling with at least 1 element of CBT
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Counseling with strong CBT focus (3+ elements)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Quality pharmacotherapy or psychotherapy
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Both quality pharmacotherapy and psychotherapy
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Satisfaction with mental health care
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Quality psychotherapy
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Number of CBT elements delivered
Number of subjects: 1004
Study: 18384466

Group type: EXPERIMENTAL
Intervention: Antidepressant drugs (2-4 types) and other psychotropic drugs
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Multiple antidepressants, tricyclic antidepressants, hypnosedatives, lithium, and/or antipsychotics
Number of subjects: 289
Study: 17065538

Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training for 2-4 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intervention group (preoperative inspiratory muscle training)
Number of subjects: 26
Study: 12934220

Group type: EXPERIMENTAL
Intervention: Histomorphologic analysis of the prosthetic bone bed
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Revision surgery
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Maximum total point motion (MTPM) analysis
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Biopsy of the bone bed
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Preoperative bone quality evaluation
Number of subjects: 23
Study: 11073508

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 66000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66000

Group type: EXPERIMENTAL
Intervention: Aspirin (doses below 163 mg/day)
Number of subjects: 66000

Group type: EXPERIMENTAL
Intervention: Modified release formulations of aspirin
Number of subjects: 66000
Study: 9339405

Group type: COMPARATOR
Intervention: 20% mannitol (M)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline solution (HS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both M and HS
Number of subjects: 50
Study: 8439639

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: 150 mg ranitidine b.d.s. plus 10 mg metoclopramide q.d.s.
Number of subjects: 0
Study: 2875321

Group type: EXPERIMENTAL
Intervention: SMS‐201‐995 0.4 microgram/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SMS‐201‐995 up to 1.6 micrograms/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SMS‐201‐995 0.8 microgram/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SMS‐201‐995
Number of subjects: 8
Study: 27863165

Group type: EXPERIMENTAL
Intervention: eHealth screening, brief intervention and referral to treatment (SBIRT)
Number of subjects: 226

Group type: COMPARATOR
Intervention: eHealth control
Number of subjects: 226
Study: 25943761

Group type: EXPERIMENTAL
Intervention: Integrated care with smoking cessation services
Number of subjects: 943

Group type: COMPARATOR
Intervention: Standard care (referral to a smoking cessation clinic)
Number of subjects: 943
Study: 24523025

Group type: EXPERIMENTAL
Intervention: Self-regulation training
Number of subjects: 55

Group type: COMPARATOR
Intervention: Dietary and physical activity advice
Number of subjects: 55
Study: 22704099

Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Fascial sling surgery
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Prior urinary incontinence surgery
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Menopausal status
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Postoperative urge index
Number of subjects: 655
Study: 20453177

Group type: EXPERIMENTAL
Intervention: Videotaped instruction of a behavioral intervention (swaddling, side positioning, white noise, jiggling, sucking)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (videotape with instructions for normal newborn care)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Videotaped instruction of a behavioral intervention
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Parenting Stress Index
Number of subjects: 51
Study: 18503600

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16001905

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound feedback, verbal, and palpatory feedback (Group 3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Verbal and palpatory feedback (Group 2)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Minimal verbal feedback (Group 1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound feedback (Group 3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Retention testing for all groups
Number of subjects: 48
Study: 12458389

Group type: EXPERIMENTAL
Intervention: Subtraction-only images
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Combined images
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sestamibi-only images
Number of subjects: 88
Study: 10219444

Group type: EXPERIMENTAL
Intervention: Chemosurgery using trichloroacetic acid (TCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nontreated side (control)
Number of subjects: 0
Study: 7553109

Group type: EXPERIMENTAL
Intervention: Excimer laser photorefractive keratectomy (PRK) with a 193nm ArF excimer laser (ExciMed, Summit) for myopic corrections of between -6.20 D and -11.90 D.
Number of subjects: 176
Study: 1971599

Group type: EXPERIMENTAL
Intervention: 5 mg tertatolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 100 mg atenolol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7426232

Group type: EXPERIMENTAL
Intervention: Stesolid (diazepam in propylene glycol)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stesolid MR (diazepam in Cremophor EL)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Diazemuls (diazepam dissolved in oil and emulsified in water)
Number of subjects: 200
Study: 30595143

Group type: EXPERIMENTAL
Intervention: Yoga group (twice-weekly group classes and once-weekly home practice focused on Iyengar-based yoga techniques)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (nonspecific muscle stretching and strengthening program)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 28836934

Group type: EXPERIMENTAL
Intervention: Tacrolimus-Sirolimus (21 patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Tacrolimus-Mycophenolate (23 patients)
Number of subjects: 44
Study: 26986743

Group type: EXPERIMENTAL
Intervention: Frequency-dependent loudness balancing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Broadband balancing
Number of subjects: 15
Study: 24890683

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/d
Number of subjects: 964

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 964
Study: 22374636

Group type: EXPERIMENTAL
Intervention: Seated with 2-min bouts of light-intensity walking every 20 min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Seated with 2-min bouts of moderate-intensity walking every 20 min
Number of subjects: 19

Group type: COMPARATOR
Intervention: Uninterrupted sitting
Number of subjects: 19
Study: 21183132

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (added to Risperidone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 0
Study: 17122092

Group type: EXPERIMENTAL
Intervention: PACAP (4x12.5 microg administered intravenously in a pulsatile fashion hourly between 2200 and 0100)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15826328

Group type: EXPERIMENTAL
Intervention: 4D ultrasound scanning
Number of subjects: 44

Group type: COMPARATOR
Intervention: 2D ultrasound scanning (control group)
Number of subjects: 44
Study: 12391470

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (Carbamazepine)
Number of subjects: 52
Study: 10447050

Group type: EXPERIMENTAL
Intervention: Lidocaine i.v. bolus (0.69 or 0.75 mg x kg(‐1)) under hyperbaric/hyperoxic conditions (HBO: 2.5 bar or 0.25 MPa)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Lidocaine i.v. bolus (0.69 or 0.75 mg x kg(‐1)) under normobaric conditions (NB: 1 bar or 0.1 MPa, air)
Number of subjects: 2
Study: 7604949

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate or beclomethasone dipropionate
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Corticosteroids (Fluticasone propionate or beclomethasone dipropionate)
Number of subjects: 7
Study: 2270529

Group type: COMPARATOR
Intervention: Platelet aggregation (PA) measurements before treatment and yearly during a 3-year period
Number of subjects: 93

Group type: COMPARATOR
Intervention: Platelet aggregation (PA) tests
Number of subjects: 93
Study: 7370358

Group type: EXPERIMENTAL
Intervention: Bogus ascending success feedback (AS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bogus equally distributed success feedback (EDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No feedback (NF)
Number of subjects: 0
Study: 31506029

Group type: EXPERIMENTAL
Intervention: Counseling based on Bandura's self-efficacy theory (6 sessions of 90 minutes each)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 96
Study: 30287669

Group type: EXPERIMENTAL
Intervention: ACT plus standard medical care (SMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical care (SMC) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACT plus SMC
Number of subjects: 0

Group type: COMPARATOR
Intervention: SMC alone
Number of subjects: 0
Study: 26733609

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT) - four 4-minute intervals at 85% to 95% of peak heart rate, 3 times a week for 12 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group - continuing regular exercise habits
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 51
Study: 24648802

Group type: EXPERIMENTAL
Intervention: D-002 (50 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23048011

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (triphasic estradiol and norethisterone acetate for women with intact uterus; 2 mg estradiol for women with hysterectomy)
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 1006

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 1006
Study: 20509942

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol (160/4.5 microg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: formoterol (4.5 microg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: salbutamol (2 x 100 microg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 18763287

Group type: EXPERIMENTAL
Intervention: C14‐urea breath test (C14‐UBT)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Serology test
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: H pylori IgG antibodies
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Negative H pylori serology test
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Positive H pylori titres
Number of subjects: 244
Study: 16249890

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IVIg) at 0.75 g/kg/day for 5 days
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous cyclosporin A (CsA) at 5 mg/kg/day for 5 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Supportive care (Control)
Number of subjects: 6
Study: 12717008

Group type: EXPERIMENTAL
Intervention: Bright light exposure (10,000 lx for 6 min fixed gaze and 5,000-9,000 lx for 6 min free gaze)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Bright light exposure
Number of subjects: 21
Study: 10762507

Group type: EXPERIMENTAL
Intervention: Unidentified bright objects (UBOs) on MRI
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Adding UBOs as a diagnostic criterion
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Agreement between two pediatric neuroradiologists
Number of subjects: 38
Study: 8941008

Group type: EXPERIMENTAL
Intervention: Paclitaxel and cisplatin
Number of subjects: 386

Group type: COMPARATOR
Intervention: Cyclophosphamide and cisplatin (standard therapy)
Number of subjects: 386
Study: 1351737

Group type: EXPERIMENTAL
Intervention: Vecuronium (n = 8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alcuronium (n = 12)
Number of subjects: 20
Study: 6373094

Group type: EXPERIMENTAL
Intervention: Cephalexin 1.0 g or 0.5 g daily on a bid regimen (30 mg/kg mean daily dose)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cephalexin 1.0 g or 0.5 g daily on a qid regimen (29 mg/kg mean daily dose)
Number of subjects: 157
Study: 30564933

Group type: EXPERIMENTAL
Intervention: Oncokompas
Number of subjects: 205
Study: 29125702

Group type: EXPERIMENTAL
Intervention: PTL101 containing 10 mg CBD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTL101 containing 100 mg CBD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sativex oromucosal spray (reference product)
Number of subjects: 0
Study: 1596595

Group type: COMPARATOR
Intervention: Pentoxifylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naftidrofuryl
Number of subjects: 10

Group type: COMPARATOR
Intervention: Other classes of drugs (vasodilators, antiplatelet drugs, anticoagulants, prostaglandins)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stopping smoking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercising regularly
Number of subjects: 10
Study: 22541408

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (200 μg/d)
Number of subjects: 962

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 962